S. A. Dawe
Research Subjects
S. A. Dawe has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
E. Higgins
Departments of Dermatology and Histopathology, Kings College Hospital, Denmark Hill, London SE5 9RS, UK
2 shared publicationsA. D. Stephens
Haematology, and
1 shared publicationA. Du Vivier
Departments of Dermatology
1 shared publicationJ. D. Creamer
Departments of Dermatology
1 shared publicationJ. S. Williams
Department of Dermatology, Kings College Hospital, Denmark Hill, London, UK
1 shared publication- Jonathan R. Salisbury
Department of Histopathology King's College Hospital NHS Foundation Trust London UK
1 shared publication
Latest Publications
- 1 November 2005
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 30 (6) , 712-713
Two cases of Bowen's disease successfully treated topically with 3% diclofenac in 2.5% hyaluronan gel
- 1 November 2005
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 30 (6) , 712-713
Two cases of Bowen's disease successfully treated topically with 3% diclofenac in 2.5% hyaluronan gel
- 1 September 2005
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 30 (5) , 607-608
Painful skin induration in a neonate
- 1 September 2005
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 30 (5) , 607-608
Painful skin induration in a neonate
- 1 November 2002
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 27 (8) , 680-683
Congenital erythropoietic porphyria: dilemmas in present day management
Congenital erythropoietic porphyria is a rare autosomal recessive disorder of haem biosynthesis caused by a deficiency of uroporphyrinogen III synthetase. There is resultant accumulation and hyperexcretion of porphyrinogens of the isomer I variety. These are converted by spontaneous oxidation into their corresponding photoactive porphyrins leading to photodamage. Accumulation of porphyrins results in haemolysis and extensive photosensitivity. The consequences of chronic haemolysis are splenomegaly, reactive erythroid hyperplasia, erythrodontia, bone fragility, extreme photosensitivity and photomutilation. We present a 35-year-old man who has the severe infantile form and illustrates the haematological and photodestructive complications despite attempts at treatment with hypertransfusion, oral charcoal therapy and beta-carotene. Allogenic bone marrow transplantation has been considered but because of the high associated mortality this procedure has been discounted at present in the management of our patient.
- 1 November 2002
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 27 (8) , 680-683
Congenital erythropoietic porphyria: dilemmas in present day management
Congenital erythropoietic porphyria is a rare autosomal recessive disorder of haem biosynthesis caused by a deficiency of uroporphyrinogen III synthetase. There is resultant accumulation and hyperexcretion of porphyrinogens of the isomer I variety. These are converted by spontaneous oxidation into their corresponding photoactive porphyrins leading to photodamage. Accumulation of porphyrins results in haemolysis and extensive photosensitivity. The consequences of chronic haemolysis are splenomegaly, reactive erythroid hyperplasia, erythrodontia, bone fragility, extreme photosensitivity and photomutilation. We present a 35-year-old man who has the severe infantile form and illustrates the haematological and photodestructive complications despite attempts at treatment with hypertransfusion, oral charcoal therapy and beta-carotene. Allogenic bone marrow transplantation has been considered but because of the high associated mortality this procedure has been discounted at present in the management of our patient.